Analytical Data
-
Gene name
TAF11
- Application
-
Alternative Names
TFIID subunit p30-beta Transcription initiation factor TFIID 28KDA subunit
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15544
-
Expression Region
1-211aa
-
Molecular Weight
50.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAF11, or TATA-binding protein-associated factor 11, is a crucial component of the transcriptional machinery in eukaryotic cells. It plays a significant role in the formation of the transcription initiation complex, thereby influencing gene expression. The study of TAF11 and its recombinant protein is essential for understanding its functional contributions to transcription regulation, as well as its potential involvement in various biological processes, including cell proliferation, differentiation, and response to stress. Alterations in TAF11 expression and function have been implicated in several diseases, including cancer, highlighting the importance of characterizing this protein for potential therapeutic applications. Recombinant TAF11 has been used in biochemical assays to elucidate its interactions with other transcription factors and regulatory proteins, providing insights into the molecular mechanisms governing transcription. Research into TAF11 also extends to its structural biology, as understanding its three-dimensional conformation can reveal how mutations or modifications affect its activity. Overall, the recombinant production of TAF11 serves as a valuable tool in the study of transcription regulation and the development of novel strategies for disease intervention.
